Sign Up to like & get
recommendations!
1
Published in 2019 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1535-7163.mct-19-0204
Abstract: Viral-based chimeric antigen receptor-engineered T (CAR T)–cell manufacturing has potential safety risks and relatively high costs. The nonviral minicircle DNA (mcDNA) is safer for patients, cheaper to produce, and may be a more suitable technique…
read more here.
Keywords:
car cells;
dna engineered;
minicircle dna;
engineered car ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1121030
Abstract: Adoptive cell therapy (ACT) has seen a steep rise of new therapeutic approaches in its immune-oncology pipeline over the last years. This is in great part due to the recent approvals of chimeric antigen receptor…
read more here.
Keywords:
cell;
tcr cells;
engineered car;
car ... See more keywords